REFERENCES
1. Rashed MH, Bayraktar E, Helal GK, Abd-Ellah MF, Amero P, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci 2017;18:538.
2. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010;73:1907-20.
3. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013;200:373-83.
4. Record M, Carayon K, Poirot M, Silvente-Poirot S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta 2014;1841:108-20.
5. Bang C, Thum T. Exosomes: new players in cell-cell communication. Int J Biochem Cell Biol 2012;44:2060-4.
6. Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012;1820:940-8.
7. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012;40:D1241-4.
8. Tian W, Liu S, Li B. Potential role of exosomes in cancer metastasis. Biomed Res Int 2019;2019:4649705.
9. Bruschi M, Ravera S, Santucci L, Candiano G, Bartolucci M, et al. The human urinary exosome as a potential metabolic effector cargo. Expert Rev Proteomics 2015;12:425-32.
10. Bruschi M, Santucci L, Ravera S, Candiano G, Bartolucci M, et al. Human urinary exosome proteome unveils its aerobic respiratory ability. J Proteomics 2016;136:25-34.
11. Panfoli I, Ravera S, Podestà M, Cossu C, Santucci L, et al. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants. FASEB J 2016;30:1416-24.
12. Bruschi M, Santucci L, Ravera S, Bartolucci M, Petretto A, Calzia D, et al. Metabolic signature of microvesicles from umbilical cord mesenchymal stem cells of preterm and term infants. Proteomics Clin Appl 2018;12:1700082.
13. Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013;10:301-12.
14. Islam MN, Das SR, Emin MT, Wei M, Sun L, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012;18:759-65.
15. Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011;33:419-40.
16. Li I, Nabet BY. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer 2019;18:32.
17. Wu M, Wang G, Hu W, Yao Y, Yu XF. Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol Cancer 2019;18:53.
18. Li W, Li C, Zhou T, Liu X, Liu X, et al. Role of exosomal proteins in cancer diagnosis. Mol Cancer 2017;16:145.
19. Kosaka N, Yoshioka Y, Hagiwara K, Tominaga N, Katsuda T, et al. Trash or Treasure: extracellular microRNAs and cell-to-cell communication. Front Genet 2013;4:173.
20. Dutta S, Warshall C, Bandyopadhyay C, Dutta D, Chandran B. Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS One 2014;9:e97580.
21. Pan J, Ding M, Xu K, Yang C, Mao LJ. Exosomes in diagnosis and therapy of prostate cancer. Oncotarget 2017;8:97693-700.
22. Zhang X, Yuan X, Shi H, Wu L, Qian H, et al. Exosomes in cancer: small particle, big player. J Hematol Oncol 2015;8:83.
23. Adem B, Vieira PF, Melo SA. Decoding the biology of exosomes in metastasis. Trends Cancer 2020;6:20-30.
24. Simpson RJ, Lim JW, Moritz RL, Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009;6:267-83.
25. Franzen CA, Blackwell RH, Foreman KE, Kuo PC, Flanigan RC, et al. Urinary exosomes: the potential for biomarker utility, intercellular signaling and therapeutics in urological malignancy. J Urol 2016;195:1331-9.
26. Panfoli I. Cancer exosomes in urine: a promising biomarker source. Transl Cancer Res 2017;6:S1389-93.
27. Gámez-Valero A, Lozano-Ramos SI, Bancu I, Lauzurica-Valdemoros R, Borràs FE. Urinary extracellular vesicles as source of biomarkers in kidney diseases. Front Immunol 2015;6:6.
28. Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 2017;14:531-48.
29. Di Meo A, Bartlett J, Cheng Y, Pasic MD, Yousef GM. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer 2017;16:80.
31. Pitt JM, Charrier M, Viaud S, André F, Besse B, et al. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer. J Immunol 2014;193:1006-11.
32. Liu C, Su C. Design strategies and application progress of therapeutic exosomes. Theranostics 2019;9:1015-28.
33. Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
34. de Vrij J, Maas SL, Kwappenberg KM, Schnoor R, Kleijn A, et al. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer 2015;137:1630-42.
35. Kanada M, Bachmann MH, Hardy JW, Frimannson DO, Bronsart L, et al. Differential fates of biomolecules delivered to target cells via extracellular vesicles. Proc Natl Acad Sci U S A 2015;112:E1433-42.
36. Prunotto M, Farina A, Lane L, Pernin A, Schifferli J, et al. Proteomic analysis of podocyte exosome-enriched fraction from normal human urine. J Proteomics 2013;82:193-229.
37. Conde-Vancells J, Rodriguez-Suarez E, Embade N, Gil D, Matthiesen R, et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 2008;7:5157-66.
38. Zhang J, Li S, Li L, Li M, Guo C, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 2015;13:17-24.
39. Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 2019;8:727.
40. Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics 2017;7:789-804.
41. Yan Z, Dutta S, Liu Z, Yu X, Mesgarzadeh N, et al. A label-free platform for identification of exosomes from different sources. ACS Sens 2019;4:488-97.
42. Hurwitz SN, Sun L, Cole KY, Ford CR 3rd, Olcese JM, et al. An optimized method for enrichment of whole brain-derived extracellular vesicles reveals insight into neurodegenerative processes in a mouse model of Alzheimer’s disease. J Neurosci Methods 2018;307:210-20.
43. Liu F, Vermesh O, Mani V, Ge TJ, Madsen SJ, et al. The exosome total isolation chip. ACS Nano 2017;11:10712-23.
44. Wu M, Ouyang Y, Wang Z, Zhang R, Huang PH, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A 2017;114:10584-9.
45. Henderson MC, Azorsa DO. The genomic and proteomic content of cancer cell-derived exosomes. Front Oncol 2012;2:38.
46. Xiao H, Wong DT. Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry. Anal Chim Acta 2012;723:61-7.
47. Jayachandran A, Manda SV, Shrestha R, Bridle KR, Prithviraj P, et al. Exosome-based liquid biopsy in the management of hepatocellular carcinoma. HR 2018;4:44.
48. Quandt D, Dieter Zucht H, Amann A, Wulf-Goldenberg A, Borrebaeck C, et al. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget 2017;8:48507-20.
49. Kim DK, Lee J, Simpson RJ, Lötvall J, Gho YS. EVpedia: a community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin Cell Dev Biol 2015;40:4-7.
50. Skotland T, Ekroos K, Kauhanen D, Simolin H, Seierstad T, et al. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers. Eur J Cancer 2017;70:122-32.
51. Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 2015;523:177-82.
52. Wang X, Luo G, Zhang K, Cao J, Huang C, et al. Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis. Cancer Res 2018;78:4586-98.
53. Bastos N, Ruivo CF, da Silva S, Melo SA. Exosomes in cancer: use them or target them? Semin Cell Dev Biol 2018;78:13-21.
54. Pullan JE, Confeld MI, Osborn JK, Kim J, Sarkar K, et al. Exosomes as drug carriers for cancer therapy. Mol Pharm 2019;16:1789-98.
55. Kanchanapally R, Deshmukh SK, Chavva SR, Tyagi N, Srivastava SK, et al. Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis. Int J Nanomedicine 2019;14:531-41.
56. Luan X, Sansanaphongpricha K, Myers I, Chen H, Yuan H, et al. Engineering exosomes as refined biological nanoplatforms for drug delivery. Acta Pharmacol Sin 2017;38:754-63.
57. Sato YT, Umezaki K, Sawada S, Mukai SA, Sasaki Y, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep 2016;6:21933.
58. Vakhshiteh F, Atyabi F, Ostad SN. Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy. Int J Nanomedicine 2019;14:2847-59.
59. Ueda N, Atsuta I, Ayukawa Y, Yamaza T, Furuhashi A, et al. Novel application method for mesenchymal stem cell therapy utilizing its attractant-responsive accumulation property. Appl Sci 2019;9:4908.
60. Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol 2019;10:1078.
61. Chen G, Huang AC, Zhang W, Zhang G, Wu M, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 2018;560:382-6.
62. Bellavia D, Raimondo S, Calabrese G, Forte S, Cristaldi M, et al. Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth. Theranostics 2017;7:1333-45.
63. Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 2016;12:655-64.
64. Bovy N, Blomme B, Frères P, Dederen S, Nivelles O, et al. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget 2015;6:10253-66.
65. Sun Z, Shi K, Yang S, Liu J, Zhou Q, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer 2018;17:147.
67. Rauschenberger L, Staar D, Thom K, Scharf C, Venz S, et al. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment. Prostate 2016;76:409-24.
